Loading…

39. Chronic stress regulates pancreatic cancer progress: A critical role for beta-adrenergic signalling

Pancreatic cancer cells intimately interact with a complex microenvironment that influences pancreatic cancer progression. The pancreas is innervated by fibers of the sympathetic nervous system (SNS), however the effect of SNS signaling on tumor progression within the pancreatic microenvironment has...

Full description

Saved in:
Bibliographic Details
Published in:Brain, behavior, and immunity behavior, and immunity, 2014-09, Vol.40, p.e12-e12
Main Authors: Kim-Fuchs, C, Le, C.P, Pimentel, M.A, Angst, E, Holland, F, Sloan, E.K
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pancreatic cancer cells intimately interact with a complex microenvironment that influences pancreatic cancer progression. The pancreas is innervated by fibers of the sympathetic nervous system (SNS), however the effect of SNS signaling on tumor progression within the pancreatic microenvironment has not previously been investigated. To investigate the effect of neural signaling on cancer progression we used in vivo optical imaging to non-invasively track growth and dissemination of primary pancreatic cancer using an orthotopic mouse model that replicates the complex interaction between pancreatic tumor cells and their microenvironment. Stress-induced neural activation increased primary tumor growth and tumor cell dissemination to normal adjacent pancreas. These effects were associated with increased expression of invasion genes by tumor cells and pancreatic stromal cells. Pharmacological activation of beta-adrenergic signaling induced similar effects to chronic stress, and pharmacological beta-blockade reversed the effects of chronic stress on pancreatic cancer progression. These findings indicate that neural-induced beta-adrenergic signaling regulates cancer progression within the pancreatic microenvironment and suggest beta-blockade as a novel strategy to complement existing therapies.
ISSN:0889-1591
1090-2139
DOI:10.1016/j.bbi.2014.06.059